Active Ingredient(s): Cerliponase Alfa
FDA Approved: * April 27, 2017
Pharm Company: * BIOMARIN PHARM
Category: Neurological Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Recent Brineura Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cerliponase Alfa
  • Injection: 30mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Brineura: (1 result)

Sorted by National Drug Code
  • 68135-811 Brineura Intraventricular Kit by Biomarin Pharmaceutical Inc.

Other drugs which contain Cerliponase Alfa or a similar ingredient: (1 result)